Search research articles
Contact Us
Filters
Showing results (41-50 of 211) with videos related to
Page
of 22
Sort By:
The New England Journal of Medicine
|
June 6, 2020
Waiting for Certainty on Covid-19 Antibody Tests - At What Cost?
Milton C Weinstein, Kenneth A Freedberg, Emily P Hyle, et al.
Vaccine
|
April 20, 2005
The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis
Anushua Sinha, Tracy A Lieu, Lawrence C Paoletti, et al.
Circulation. Cardiovascular Quality and Outcomes
|
January 16, 2014
Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines
Ankur Pandya, Milton C Weinstein, Joshua A Salomon, et al.
American Journal of Public Health
|
October 5, 2006
Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification
Tanya G K Bentley, Walter C Willett, Milton C Weinstein, et al.
Cancer
|
December 19, 2018
A decision analysis comparing 3 active surveillance protocols for the treatment of patients with low-risk prostate cancer
Craig White, Tony Nimeh, G Scott Gazelle, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
August 8, 2013
Sequential value-of-information assessment for prospective drug safety monitoring using claims databases: the comparative safety of prasugrel v. clopidogrel
Amanda R Patrick, Jessica M Franklin, Milton C Weinstein, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 12, 2017
Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves
Ankur Pandya, Stephen Sy, Sylvia Cho, et al.
Circulation
|
December 7, 2005
Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level
Thomas A Gaziano, Krisela Steyn, David J Cohen, et al.
Health Care Financing Review
|
February 10, 2007
Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment
Bruce R Schackman, Kenneth A Freedberg, Sue J Goldie, et al.
Human Vaccines & Immunotherapeutics
|
September 22, 2021
The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
Michele A Kohli, Michael Maschio, Joaquin F Mould-Quevedo, et al.
Page
of 22
Search research articles
Search
Showing results (41-50 of 211) with videos related to
Sort By:
Page
of 22
The New England Journal of Medicine
|
June 6, 2020
Waiting for Certainty on Covid-19 Antibody Tests - At What Cost?
Milton C Weinstein, Kenneth A Freedberg, Emily P Hyle, et al.
Vaccine
|
April 20, 2005
The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis
Anushua Sinha, Tracy A Lieu, Lawrence C Paoletti, et al.
Circulation. Cardiovascular Quality and Outcomes
|
January 16, 2014
Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines
Ankur Pandya, Milton C Weinstein, Joshua A Salomon, et al.
American Journal of Public Health
|
October 5, 2006
Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification
Tanya G K Bentley, Walter C Willett, Milton C Weinstein, et al.
Cancer
|
December 19, 2018
A decision analysis comparing 3 active surveillance protocols for the treatment of patients with low-risk prostate cancer
Craig White, Tony Nimeh, G Scott Gazelle, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
August 8, 2013
Sequential value-of-information assessment for prospective drug safety monitoring using claims databases: the comparative safety of prasugrel v. clopidogrel
Amanda R Patrick, Jessica M Franklin, Milton C Weinstein, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 12, 2017
Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves
Ankur Pandya, Stephen Sy, Sylvia Cho, et al.
Circulation
|
December 7, 2005
Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level
Thomas A Gaziano, Krisela Steyn, David J Cohen, et al.
Health Care Financing Review
|
February 10, 2007
Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment
Bruce R Schackman, Kenneth A Freedberg, Sue J Goldie, et al.
Human Vaccines & Immunotherapeutics
|
September 22, 2021
The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
Michele A Kohli, Michael Maschio, Joaquin F Mould-Quevedo, et al.
Page
of 22